SCHEMBL21734119

SCHEMBL21734119

CC[C@H](Nc1nnc(C)cc1C)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATP1A1 P05023 1/20 0.41
▸ ATP1B1 P05026 1/20 0.41
▸ ATP1A3 P13637 1/20 0.41
▸ ATP1B2 P14415 1/20 0.41
▸ ATP1A2 P50993 1/20 0.41
▸ ATP1B3 P54709 1/20 0.41
▸ FXYD2 P54710 1/20 0.41
▸ ATP1A4 Q13733 1/20 0.41
▸ MAPK1 P28482 6/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ UTS2R Q9UKP6 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ CRHR1 P34998 4/20 0.33
▸ ACHE P22303 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21555165 1.00 ATP1A1 (0.41) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL17723403 0.86 ATP1A1 (0.39) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL17723357 0.86 ATP1A1 (0.39) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL21734351 0.81 LDHA (0.41) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL21555164 0.81 LDHA (0.41) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL21734106 0.77 ATP1A1 (0.45) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL17723385 0.75 ATP1A1 (0.39) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL17723360 0.75 ATP1A1 (0.39) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL17723386 0.72 HDAC6 (0.40) EGFR
SCHEMBL17723366 0.72 HDAC6 (0.40) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117884-B2 Potent gamma-secretase modulators THE GENERAL HOSPITAL CORPORATION (US) 2021-09-14 — — US disclosed
US-20200055840-A1 POTENT GAMMA-SECRETASE MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200055840-A1 POTENT GAMMA-SECRETASE MODULATORS BACE1, BACE2, GSAP ATP1A1 3069/4885ATP1B1 2567/4885ATP1A3 2648/4885
US-11117884-B2 Potent gamma-secretase modulators BACE1, BACE2, GSAP ATP1A1 3069/4885ATP1B1 2567/4885ATP1A3 2648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback